US Patent Issued to DAEWOONG THERAPEUTICS, DAEWOONG PHARMACEUTICAL on May 26 for "Niclosamide delayed-release composition and antiviral use thereof" (South Korean Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,267, issued on May 26, was assigned to DAEWOONG THERAPEUTICS INC. (Suwon-si, South Korea) and DAEWOONG PHARMACEUTICAL Co. LTD. (Hwaseong-si, South Korea).

"Niclosamide delayed-release composition and antiviral use thereof" was invented by Minsuk Lee (Seoul, South Korea), Bokki Kang (Seongnam-si, South Korea), Sanghan Park (Seoul, South Korea) and Donghwan Kim (Suwon-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition for prevention or treatment of coronavirus infections, comprising a delayed-release composition of niclosamide or a pharmaceutically acceptable salt thereof, and a ...